BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15191552)

  • 1. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis.
    Wang XP; Schunck M; Kallen KJ; Neumann C; Trautwein C; Rose-John S; Proksch E
    J Invest Dermatol; 2004 Jul; 123(1):124-31. PubMed ID: 15191552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin.
    Wood LC; Stalder AK; Liou A; Campbell IL; Grunfeld C; Elias PM; Feingold KR
    Exp Dermatol; 1997 Apr; 6(2):98-104. PubMed ID: 9209892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
    Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
    Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No inhibition of IL-27 signaling by soluble gp130.
    Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S
    Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
    Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
    Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
    Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro.
    Rakemann T; Niehof M; Kubicka S; Fischer M; Manns MP; Rose-John S; Trautwein C
    J Biol Chem; 1999 Jan; 274(3):1257-66. PubMed ID: 9880494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influx of calcium and chloride ions into epidermal keratinocytes regulates exocytosis of epidermal lamellar bodies and skin permeability barrier homeostasis.
    Denda M; Fuziwara S; Inoue K
    J Invest Dermatol; 2003 Aug; 121(2):362-7. PubMed ID: 12880429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of voltage-gated calcium channel subunit alpha1C in epidermal keratinocytes and effects of agonist and antagonists of the channel on skin barrier homeostasis.
    Denda M; Fujiwara S; Hibino T
    Exp Dermatol; 2006 Jun; 15(6):455-60. PubMed ID: 16689862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing.
    Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
    J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T; Ishihara K; Hibi M
    Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 receptor independent stimulation of human gp130 by viral IL-6.
    Müllberg J; Geib T; Jostock T; Hoischen SH; Vollmer P; Voltz N; Heinz D; Galle PR; Klouche M; Rose-John S
    J Immunol; 2000 May; 164(9):4672-7. PubMed ID: 10779772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA-type glutamate receptor is associated with cutaneous barrier homeostasis.
    Fuziwara S; Inoue K; Denda M
    J Invest Dermatol; 2003 Jun; 120(6):1023-9. PubMed ID: 12787130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
    Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
    J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
    Yoshida S; Harada T; Iwabe T; Taniguchi F; Mitsunari M; Yamauchi N; Deura I; Horie S; Terakawa N
    Hum Reprod; 2004 Aug; 19(8):1821-5. PubMed ID: 15166129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis.
    Denda M; Tsutsumi M; Denda S
    Exp Dermatol; 2010 Sep; 19(9):791-5. PubMed ID: 20636355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of IL-6-induced STAT activation is independent of receptor internalization but requires de novo protein synthesis.
    Thiel S; Sommer U; Kortylewski M; Haan C; Behrmann I; Heinrich PC; Graeve L
    FEBS Lett; 2000 Mar; 470(1):15-9. PubMed ID: 10722837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.